Stay updated on IMmotion151: Atezo + Bev vs Sunitinib in Untreated Adv RCC Clinical Trial
Sign up to get notified when there's something new on the IMmotion151: Atezo + Bev vs Sunitinib in Untreated Adv RCC Clinical Trial page.

Latest updates to the IMmotion151: Atezo + Bev vs Sunitinib in Untreated Adv RCC Clinical Trial page
- Check4 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.5%
- Check11 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.5%
- Check18 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information. This suggests a shift towards a more generalized presentation of location data.SummaryDifference67%
- Check25 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%
- Check40 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11, indicating a revision in the content.SummaryDifference0.3%
- Check47 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference4%
Stay in the know with updates to IMmotion151: Atezo + Bev vs Sunitinib in Untreated Adv RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMmotion151: Atezo + Bev vs Sunitinib in Untreated Adv RCC Clinical Trial page.